U.S., June 28 -- ClinicalTrials.gov registry received information related to the study (NCT07041827) titled 'Cardiotoxicity and Other Late Effects After Radiotherapy and Immuno-chemoTherapy in Non-Hodgkin lYmphoma' on Feb. 20, 2019.
Brief Summary: Survivors of non-Hodgkin lymphoma and a control group will be screened for (sub)clinical cardiovascular disease, to assess the influence of contemporary treatments on risk and burden of (sub)clinical cardiovascular disease and their influence on survival.
Study Start Date: Feb. 01, 2020
Study Type: OBSERVATIONAL
Condition:
Non Hodgkin Lymphoma
DLBCL
Cardiovascular Diseases
Cardiomyopathies
Cardiotoxicity
Metabolic Syndrome
Quality of Life
Late Effect
Heart Failure
Intervention:
DIAGNOSTIC_T...